PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
12-May-2025 Thermosome Receives U.S. Orphan Drug Designation for Lead Compound THE001, Expands Patent Estate Thermosome
09-May-2025 Tiziana Life Sciences Announces Significant Reduction in Microglia Activation in PET Scan of Moderate Alzheimer's Patient Treated with Intranasal Foralumab Tiziana Life Sciences
09-May-2025 NextCell CSO Lindsay Davies Honoured with Multiple New Leadership Roles Within European Cell Therapy Community NextCell Pharma AB
09-May-2025 Likarda Paper Highlights Hydrogel Encapsulation with CSS Can Overcome Major Obstacle of Liver Cell Therapies Likarda
09-May-2025 Title21 Names Advisory Committee to Build Cell Therapy Expertise Title21
08-May-2025 EvoSelect®, A Machine Learning Enzyme Engineering Tool is Released! Isomerase
08-May-2025 Fluoropolymers Recently Diversified at Alfa Chemistry: FEP (Fluorinated Ethylene Propylene), PFA (Perfluoroalkoxy Alkane), PEEK (Polyetheretherketone) Added Alfa Chemistry
08-May-2025 Everest Medicines Announces NMPA Full Approval of NEFECON, Broadening Treatment Access for IgA Nephropathy Patients in China Everest Medicines Limited
07-May-2025 Personalized Treatment Plans Influence European Public’s Willingness to Share Health Data Johnson & Johnson MedTech
07-May-2025 ELRIG Announces Keynote Speakers for Drug Discovery 2025 ELRIG
07-May-2025 Domainex Appoints Hayley French as Chief Executive Officer Domainex
07-May-2025 Cell Analyzer Market to Reach New Heights by 2030: Unveiling Opportunities in Regenerative Medicine, and Stem Cell Research Medi-Tech Insights
06-May-2025 Clean Biologics appoints Laurent Claisse as CEO to accelerate US and global market expansion  Andrew Lloyd Associates
01-May-2025 UK Company, Stablepharma Ltd, enters Phase 1 Clinical Trials with world-first Fridge-Free Tetanus & Diphtheria Vaccine Stablepharma Ltd
01-May-2025 Nxera Pharma’s Partner Neurocrine Biosciences Initiates Phase 3 Registrational Program of NBI-1117568 as a Potential Treatment for Adults with Schizophrenia Nxera
01-May-2025 Nxera Pharma Appoints Top-Ranked Biopharma Investment Analyst Shinya Tsuzuki as Head of Investor Relations Nxera
30-Apr-2025 Domain Therapeutics Presents Novel Data Addressing Key Challenges in Oncology at AACR 2025 Domain Therapeutics
30-Apr-2025 Isomerase Enhances Process Innovation Capabilities for Protein Discovery and Production Isomerase
29-Apr-2025 Novadip releases five-year follow-up results for NVD003, regenerative treatment for severe bone non-union of lower limb Andrew Lloyd Associates
28-Apr-2025 Single-use Bioprocessing: A Rapidly Growing Frontier in Biomanufacturing futurewiseresearch